Skip to content

Three Quick Facts: Various Eateries, Spectris and Vela Technologies

Three Quick Facts: Various Eateries, Spectris and Vela Technologies

Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.

#1.  Post-lockdown rebound cheers growing Various Eateries

Various Eateries LON:VARE has published results for the 53 weeks to 3rd October this morning. The company runs the Coppa Club chain and notes that sales across the franchise from COVID reopening in mid-May to the end of the financial year were some 21% up on pre-pandemic figures. That has arguably been bolstered by an expansion of the estate too – which continues – with a further 25% uptick in non-London sales being recorded after ‘Plan B’ restrictions were lifted at the start of the calendar year. The company also noted that hotel occupancy and average room rates were above 2019 levels post-reopening.

#2. Spectris calls off bid in wake of Ukraine war

Spectris LON:SXS has this morning issued a statement noting that it now no longer has an interest in making a firm offer for Oxford Instruments. Citing the economic uncertainty created off the back of Russia’s invasion of Ukraine as the driver here is certainly a profound statement to make given Spectris notes it has no operations in Ukraine.

#3. Vela Technologies portfolio company delivers upbeat clinical results

Vela Technologies LON:VELA has published an update regarding portfolio company St George Street Capital, which has just released an update of tests for its COVID therapy trial. The results are encouraging to the extent that it now enables active engagement with prospective commercial partners. Management note that they believe the AZD1656 treatment has the potential to show a healthy return for SGSC and therefore Vela, too.

Share this article

Invest with these platforms

Hargreaves Lansdown

IG

Interactive Brokers

Interactive Investor

Charles Stanley

IG

Interactive Brokers

Charles Stanley

Looking for great investing ideas? Get our free newsletter.
Join our UK news channel on WhatsApp

This article does not constitute investment advice.  Do your own research or consult a professional advisor.

Learn with our free 'How to' Guides

Our latest in-depth company reports

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
Schroders

aberdeen
WisdomTree
ARK
Plus500
CMC Markets
Back To Top